Amgen is a global biopharmaceutical company that discovers, develops, and manufactures medicines across multiple therapeutic areas including rheumatology, oncology, bone health, cardiovascular disease, and immunology. The company's portfolio includes blockbuster drugs such as Enbrel for rheumatoid arthritis, Repatha for cardiovascular risk reduction, Prolia for osteoporosis, and various cancer treatments, with products distributed through pharmaceutical wholesalers to hospitals, clinics, and pharmacies. Amgen maintains several partnership agreements with other pharmaceutical and biotech firms to expand its pipeline and commercialize treatments.

entry readiness 45 · WEAK SETUP · exit proximity 0

Value area 318.88–379.03 · 27% of 120d volume overhead · moderate overhead